Novartis Ag Adr Stock Shares Owned By Insiders

NVS Stock

USD 105.77 0.90 0.86%

Novartis AG ADR fundamentals help investors to digest information that contributes to Novartis' financial success or failures. It also enables traders to predict the movement of Novartis Stock. The fundamental analysis module provides a way to measure Novartis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Novartis stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Novartis AG ADR Company Shares Owned By Insiders Analysis

Novartis' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Insiders Shares

Executives Shares

+

Employees

More About Shares Owned By Insiders | All Equity Analysis

Novartis Shares Owned By Insiders Driver Correlations

Understanding the fundamental principles of building solid financial models for Novartis is extremely important. It helps to project a fair market value of Novartis Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since Novartis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Novartis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Novartis' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Capital Stock	Short Term Debt	Common Stock	Intangible Assets	Long Term Debt	Good Will	Treasury Stock	Property Plant Equipment	Net Tangible Assets	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Cash And Equivalents	Net Invested Capital	Net Working Capital
Total Assets		0.92	0.52	0.71	0.92	0.92	0.76	-0.01	0.88	0.41	-0.07	0.55	-0.07	0.93	0.76	0.98	-0.06	0.83	0.1	0.37	0.26	-0.36	0.19	0.29	0.26	0.04
Total Stockholder Equity	0.92		0.65	0.43	0.99	0.83	0.76	-0.08	0.62	0.26	0.12	0.28	0.12	0.77	0.47	0.92	-0.28	0.88	0.42	0.25	0.38	-0.27	-0.14	0.17	0.45	0.18
Current Deferred Revenue	0.52	0.65		0.12	0.69	0.35	0.22	-0.26	0.26	0.04	0.1	-0.07	0.1	0.33	0.28	0.47	-0.27	0.44	0.46	0.21	0.5	-0.72	-0.16	0.03	0.31	0.1
Net Debt	0.71	0.43	0.12		0.47	0.61	0.55	0.14	0.88	0.23	-0.25	0.62	-0.25	0.85	0.91	0.68	0.15	0.35	-0.43	0.36	0.15	-0.29	0.58	0.24	-0.05	-0.18
Retained Earnings	0.92	0.99	0.69	0.47		0.82	0.74	-0.06	0.65	0.28	0.08	0.27	0.08	0.79	0.53	0.92	-0.23	0.85	0.4	0.3	0.37	-0.36	-0.09	0.19	0.41	0.2
Accounts Payable	0.92	0.83	0.35	0.61	0.82		0.68	-0.01	0.84	0.43	-0.12	0.49	-0.12	0.87	0.66	0.94	-0.06	0.87	-0.01	0.18	0.09	-0.28	0.14	0.15	0.07	0.02
Net Receivables	0.76	0.76	0.22	0.55	0.74	0.68		-0.16	0.6	0.11	0.0	0.35	0.0	0.75	0.5	0.82	-0.25	0.78	0.21	0.27	0.23	0.06	0.05	0.15	0.25	0.01
Short Term Investments	-0.01	-0.08	-0.26	0.14	-0.06	-0.01	-0.16		0.08	0.67	-0.12	-0.06	-0.12	0.08	0.17	-0.03	0.19	-0.35	-0.16	0.05	-0.53	-0.01	0.2	0.24	0.01	0.76
Total Liab	0.88	0.62	0.26	0.88	0.65	0.84	0.6	0.08		0.49	-0.27	0.75	-0.27	0.92	0.93	0.85	0.2	0.59	-0.29	0.43	0.08	-0.39	0.53	0.37	-0.02	-0.12
Total Current Assets	0.41	0.26	0.04	0.23	0.28	0.43	0.11	0.67	0.49		-0.38	0.36	-0.38	0.36	0.48	0.36	0.36	0.11	-0.15	0.35	-0.57	-0.34	0.42	0.51	-0.12	0.58
Capital Stock	-0.07	0.12	0.1	-0.25	0.08	-0.12	0.0	-0.12	-0.27	-0.38		-0.25	1.0	-0.19	-0.39	-0.05	-0.78	0.03	0.72	-0.36	0.67	0.48	-0.77	-0.37	0.84	-0.11
Short Term Debt	0.55	0.28	-0.07	0.62	0.27	0.49	0.35	-0.06	0.75	0.36	-0.25		-0.25	0.62	0.62	0.49	0.36	0.29	-0.35	0.59	-0.04	-0.06	0.52	0.51	0.0	-0.36
Common Stock	-0.07	0.12	0.1	-0.25	0.08	-0.12	0.0	-0.12	-0.27	-0.38	1.0	-0.25		-0.19	-0.39	-0.05	-0.78	0.03	0.72	-0.36	0.67	0.48	-0.77	-0.37	0.84	-0.11
Intangible Assets	0.93	0.77	0.33	0.85	0.79	0.87	0.75	0.08	0.92	0.36	-0.19	0.62	-0.19		0.83	0.93	0.05	0.69	-0.12	0.42	0.13	-0.31	0.33	0.3	0.11	0.02
Long Term Debt	0.76	0.47	0.28	0.91	0.53	0.66	0.5	0.17	0.93	0.48	-0.39	0.62	-0.39	0.83		0.71	0.3	0.38	-0.36	0.51	0.04	-0.53	0.71	0.41	-0.13	-0.04
Good Will	0.98	0.92	0.47	0.68	0.92	0.94	0.82	-0.03	0.85	0.36	-0.05	0.49	-0.05	0.93	0.71		-0.14	0.87	0.12	0.3	0.22	-0.29	0.11	0.18	0.24	0.04
Treasury Stock	-0.06	-0.28	-0.27	0.15	-0.23	-0.06	-0.25	0.19	0.2	0.36	-0.78	0.36	-0.78	0.05	0.3	-0.14		-0.21	-0.63	0.41	-0.53	-0.26	0.76	0.5	-0.6	0.07
Property Plant Equipment	0.83	0.88	0.44	0.35	0.85	0.87	0.78	-0.35	0.59	0.11	0.03	0.29	0.03	0.69	0.38	0.87	-0.21		0.27	0.07	0.31	-0.12	-0.11	-0.01	0.22	-0.09
Net Tangible Assets	0.1	0.42	0.46	-0.43	0.4	-0.01	0.21	-0.16	-0.29	-0.15	0.72	-0.35	0.72	-0.12	-0.36	0.12	-0.63	0.27		0.0	0.52	0.2	-0.74	-0.05	0.8	0.28
Deferred Long Term Liab	0.37	0.25	0.21	0.36	0.3	0.18	0.27	0.05	0.43	0.35	-0.36	0.59	-0.36	0.42	0.51	0.3	0.41	0.07	0.0		-0.06	-0.27	0.5	0.81	0.04	0.1
Long Term Investments	0.26	0.38	0.5	0.15	0.37	0.09	0.23	-0.53	0.08	-0.57	0.67	-0.04	0.67	0.13	0.04	0.22	-0.53	0.31	0.52	-0.06		0.02	-0.38	-0.21	0.66	-0.44
Short Long Term Debt	-0.36	-0.27	-0.72	-0.29	-0.36	-0.28	0.06	-0.01	-0.39	-0.34	0.48	-0.06	0.48	-0.31	-0.53	-0.29	-0.26	-0.12	0.2	-0.27	0.02		-0.4	-0.19	0.33	-0.12
Long Term Debt Total	0.19	-0.14	-0.16	0.58	-0.09	0.14	0.05	0.2	0.53	0.42	-0.77	0.52	-0.77	0.33	0.71	0.11	0.76	-0.11	-0.74	0.5	-0.38	-0.4		0.5	-0.57	-0.08
Cash And Equivalents	0.29	0.17	0.03	0.24	0.19	0.15	0.15	0.24	0.37	0.51	-0.37	0.51	-0.37	0.3	0.41	0.18	0.5	-0.01	-0.05	0.81	-0.21	-0.19	0.5		-0.03	0.3
Net Invested Capital	0.26	0.45	0.31	-0.05	0.41	0.07	0.25	0.01	-0.02	-0.12	0.84	0.0	0.84	0.11	-0.13	0.24	-0.6	0.22	0.8	0.04	0.66	0.33	-0.57	-0.03		0.1
Net Working Capital	0.04	0.18	0.1	-0.18	0.2	0.02	0.01	0.76	-0.12	0.58	-0.11	-0.36	-0.11	0.02	-0.04	0.04	0.07	-0.09	0.28	0.1	-0.44	-0.12	-0.08	0.3	0.1

Click cells to compare fundamentals

Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

Competition

Predict Novartis

Based on the latest financial disclosure, 0.0% of Novartis AG ADR are shares owned by insiders. This is 100.0% lower than that of the Pharmaceuticals sector and about the same as Health Care (which currently averages 0.0) industry. The shares owned by insiders for all United States stocks is 100.0% higher than that of the company.

Novartis Shares Owned By Insiders Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Novartis' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Novartis could also be used in its relative valuation, which is a method of valuing Novartis by comparing valuation metrics of similar companies.

Novartis is currently under evaluation in shares owned by insiders category among its peers.

Novartis ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Novartis' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Novartis' managers, analysts, and investors.

Environmental

Governance

Social

Novartis Fundamentals

	Return On Equity	0.29
	Return On Asset	0.11
	Profit Margin	0.35 %
	Operating Margin	0.33 %
	Current Valuation	229.44 B
	Shares Outstanding	2 B
	Shares Owned By Institutions	6.74 %
	Number Of Shares Shorted	4.79 M
	Price To Earning	9.22 X
	Price To Book	4.88 X
	Price To Sales	4.23 X
	Revenue	46.66 B
	Gross Profit	36.74 B
	EBITDA	18.29 B
	Net Income	8.57 B
	Cash And Equivalents	4.64 B
	Cash Per Share	8.84 X
	Total Debt	26.35 B
	Debt To Equity	0.47 %
	Current Ratio	1.31 X
	Book Value Per Share	21.67 X
	Cash Flow From Operations	14.46 B
	Short Ratio	3.83 X
	Earnings Per Share	5.73 X
	Price To Earnings To Growth	3.15 X
	Target Price	116.16
	Number Of Employees	76.06 K
	Beta	0.51
	Market Capitalization	211.46 B
	Total Asset	99.94 B
	Retained Earnings	49.65 B
	Working Capital	4.09 B
	Current Asset	22.84 B
	Current Liabilities	23.71 B
	Annual Yield	0.04 %
	Five Year Return	3.53 %
	Net Asset	99.94 B
	Last Dividend Paid	3.92

About Novartis Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Novartis AG ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novartis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novartis AG ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Novartis Stock Analysis

When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC